fda warning letters compounded glp-1 september 2025 Semaglutide & Tirzepatide 2025: Safe Use Guide US FDA creates 'green list'

Additionally, liraglutide significantly increased norepinephrine (NE) levels in both plasma and caecal contents

Geographic Healthcare Deserts: The concentration of specialized weight loss care in urban centers creates access disparities for millions of Americans

In at least six states, lawmakers ultimately walked away after closer review

Among employers covering GLP-1 agonist drugs for weight loss, most firms view it as important or very important for employee satisfaction The meaningful shares of larger employers covering these medications for weight loss, notwithstanding their relatively high cost, underscores the importance many employers place on covering these medications for employees

Beyond endothelial dysfunction, pericyte impairment has been identified as a contributor to diabetic ED [188]

How does Saxenda work for weight loss